Short Term, Oral Supplementation with Optimized Curcumin Does Not Impair Performance Improvements Associated with High Intensity Interval Training
Curcumin may improve athletic performance through a reduction in inflammation following exercise and improve mental states of well-being. The purpose of this investigation was to explore the effects of a 14 day HIIT intervention and oral supplementation with Longvida® optimized curcumin on athletic performance, lactate response, and well-being. Sixteen males and twenty females participated in a double-blinded, randomized, placebo-controlled trial to explore the effects of Longvida(R) optimized curcumin (1.0 g/day) and or a placebo (PLA) taken daily during a 14 day HIIT protocol. Participants were randomized into two groups, then evaluated in three groups, curcumin-fast (CURF), curcumin-slow (CURS) and placebo. Curcumin-fast and curcumin-slow were separated by their 16.1 km cycling time trial performance (TT) with CURF and CURS determined by a TT <30 min and >30 min at the pre intervention time point, respectively. Cycling time-trial performance, blood lactate response, and well-being assessments were determined at pre and post 14 day HIIT intervention time points. Blood lactate was recorded at baseline, 8.01 km, 15.1 km, and 1 min post, and 4 min post of the pre and post intervention TT. Following the internvetion, CONP and CURS experienced with 8.15% and 5.04% improvements in TT performance times, while CURF experienced a 0.57% improvement in TT performance time. No changes were observed with respect to other measures. When curcumin is taken daily in conjunction with 14 days of HIIT on a cycle ergometer, cycling performance in either well trained or more recreationally trained athletes is not impaired. Although the improvements in TT performance were not stasticially significant, they are noteworthy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Journal of dietary supplements - 19(2022), 6 vom: 04., Seite 733-746 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kisiolek, Jacob N [VerfasserIn] |
---|
Links: |
---|
Themen: |
33X04XA5AT |
---|
Anmerkungen: |
Date Completed 27.10.2022 Date Revised 27.10.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/19390211.2021.1936335 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326628673 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326628673 | ||
003 | DE-627 | ||
005 | 20231225195014.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/19390211.2021.1936335 |2 doi | |
028 | 5 | 2 | |a pubmed24n1088.xml |
035 | |a (DE-627)NLM326628673 | ||
035 | |a (NLM)34114918 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kisiolek, Jacob N |e verfasserin |4 aut | |
245 | 1 | 0 | |a Short Term, Oral Supplementation with Optimized Curcumin Does Not Impair Performance Improvements Associated with High Intensity Interval Training |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.10.2022 | ||
500 | |a Date Revised 27.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Curcumin may improve athletic performance through a reduction in inflammation following exercise and improve mental states of well-being. The purpose of this investigation was to explore the effects of a 14 day HIIT intervention and oral supplementation with Longvida® optimized curcumin on athletic performance, lactate response, and well-being. Sixteen males and twenty females participated in a double-blinded, randomized, placebo-controlled trial to explore the effects of Longvida(R) optimized curcumin (1.0 g/day) and or a placebo (PLA) taken daily during a 14 day HIIT protocol. Participants were randomized into two groups, then evaluated in three groups, curcumin-fast (CURF), curcumin-slow (CURS) and placebo. Curcumin-fast and curcumin-slow were separated by their 16.1 km cycling time trial performance (TT) with CURF and CURS determined by a TT <30 min and >30 min at the pre intervention time point, respectively. Cycling time-trial performance, blood lactate response, and well-being assessments were determined at pre and post 14 day HIIT intervention time points. Blood lactate was recorded at baseline, 8.01 km, 15.1 km, and 1 min post, and 4 min post of the pre and post intervention TT. Following the internvetion, CONP and CURS experienced with 8.15% and 5.04% improvements in TT performance times, while CURF experienced a 0.57% improvement in TT performance time. No changes were observed with respect to other measures. When curcumin is taken daily in conjunction with 14 days of HIIT on a cycle ergometer, cycling performance in either well trained or more recreationally trained athletes is not impaired. Although the improvements in TT performance were not stasticially significant, they are noteworthy | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a antioxidant | |
650 | 4 | |a cytokine | |
650 | 4 | |a supplement | |
650 | 7 | |a Curcumin |2 NLM | |
650 | 7 | |a IT942ZTH98 |2 NLM | |
650 | 7 | |a Lactic Acid |2 NLM | |
650 | 7 | |a 33X04XA5AT |2 NLM | |
650 | 7 | |a Polyesters |2 NLM | |
700 | 1 | |a Kheredia, Nikeeta |e verfasserin |4 aut | |
700 | 1 | |a Flores, Victoria |e verfasserin |4 aut | |
700 | 1 | |a Ramani, Arjun |e verfasserin |4 aut | |
700 | 1 | |a Lisano, Jonathon |e verfasserin |4 aut | |
700 | 1 | |a Johnston, Nora |e verfasserin |4 aut | |
700 | 1 | |a Stewart, Laura K |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of dietary supplements |d 2008 |g 19(2022), 6 vom: 04., Seite 733-746 |w (DE-627)NLM192571656 |x 1939-022X |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2022 |g number:6 |g day:04 |g pages:733-746 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/19390211.2021.1936335 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2022 |e 6 |b 04 |h 733-746 |